132 related articles for article (PubMed ID: 15816548)
1. Cyclin D1 overexpression is associated with estrogen receptor expression in Caucasian but not African-American breast cancer.
Joe AK; Memeo L; Mckoy J; Mansukhani M; Liu H; Avila-Bront A; Romero J; Li H; Troxel A; Hibshoosh H
Anticancer Res; 2005; 25(1A):273-81. PubMed ID: 15816548
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer.
Joe AK; Arber N; Bose S; Heitjan D; Zhang Y; Weinstein IB; Hibshoosh H
Anticancer Res; 2001; 21(5):3535-9. PubMed ID: 11848520
[TBL] [Abstract][Full Text] [Related]
3. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status.
Oh YL; Choi JS; Song SY; Ko YH; Han BK; Nam SJ; Yang JH
Pathol Int; 2001 Feb; 51(2):94-9. PubMed ID: 11169147
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma.
Porter PL; Lund MJ; Lin MG; Yuan X; Liff JM; Flagg EW; Coates RJ; Eley JW
Cancer; 2004 Jun; 100(12):2533-42. PubMed ID: 15197793
[TBL] [Abstract][Full Text] [Related]
5. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients.
Reed W; Flørems VA; Holm R; Hannisdal E; Nesland JM
Virchows Arch; 1999 Aug; 435(2):116-24. PubMed ID: 10599310
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast.
Leong AC; Hanby AM; Potts HW; Tan DS; Skilton D; Ryder K; Harris WH; Liebmann RD; Barnes DM; Gillett CE
Int J Cancer; 2000 Jan; 89(1):26-31. PubMed ID: 10719727
[TBL] [Abstract][Full Text] [Related]
9. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ER, PR and cyclin D1 in breast infiltrating ductal carcinoma and their clinicopathological significance].
Wang ZB; Zhao P; Liu M; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):514-7. PubMed ID: 15949328
[TBL] [Abstract][Full Text] [Related]
11. [High expression of cyclin D1 is correlated with the expression of estrogen receptor and good prognosis in breast cancer].
Yang C; Nan K; Zhang Y; Chen Y; Qin S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):84-7. PubMed ID: 26728382
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.
Kenny FS; Hui R; Musgrove EA; Gee JM; Blamey RW; Nicholson RI; Sutherland RL; Robertson JF
Clin Cancer Res; 1999 Aug; 5(8):2069-76. PubMed ID: 10473088
[TBL] [Abstract][Full Text] [Related]
13. Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
Tan F; Mosunjac M; Adams AL; Adade B; Taye O; Hu Y; Rizzo M; Ofori-Acquah SF
BMC Cancer; 2014 Sep; 14():715. PubMed ID: 25255861
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
15. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.
Tawfik O; Davis K; Kimler BF; Davis MK; Hull S; Fan F; Khan QJ; O'Dea AP; Thomas P
Ann Clin Lab Sci; 2010; 40(4):315-23. PubMed ID: 20947804
[TBL] [Abstract][Full Text] [Related]
17. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
[TBL] [Abstract][Full Text] [Related]
18. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
19. Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
Chu QD; Burton G; Glass J; Smith MH; Li BD
J Am Coll Surg; 2010 May; 210(5):585-92, 592-4. PubMed ID: 20421009
[TBL] [Abstract][Full Text] [Related]
20. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
